CIK 0001835597 · <br>Emerging growth company
PepGen Inc.
Sign in to watch- Ticker
- PEPG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 703-456-8000
- Business address
- 1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-08 | McArthur James G President and CEO | Sale 10b5-1 | −2,381 | $16.04 | $38K | 0 |
| 2023-06-08 | McArthur James G President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,381 | 325,054 | ||
| 2023-06-07 | McArthur James G President and CEO | Option exercise 10b5-1 | +8,419 | $2.71 | $23K | 8,419 |
| 2023-06-07 | McArthur James G President and CEO | Sale 10b5-1 | −8,419 | $16.23 | $137K | 0 |
| 2023-06-07 | McArthur James G President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,419 | 327,435 | ||
| 2023-06-06 | McArthur James G President and CEO | Option exercise 10b5-1 | +18,150 | $2.71 | $49K | 18,150 |
| 2023-06-06 | McArthur James G President and CEO | Sale 10b5-1 | −18,150 | $16.18 | $294K | 0 |
| 2023-06-06 | McArthur James G President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,150 | 335,854 | ||
| 2023-06-05 | McArthur James G President and CEO | Option exercise 10b5-1 | +500 | $2.71 | $1K | 500 |
| 2023-06-05 | McArthur James G President and CEO | Sale 10b5-1 | −500 | $16.06 | $8K | 0 |
| 2023-06-05 | McArthur James G President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −500 | 354,004 | ||
| 2023-06-02 | McArthur James G President and CEO | Option exercise 10b5-1 | +1,800 | $2.71 | $5K | 1,800 |
| 2023-06-02 | McArthur James G President and CEO | Sale 10b5-1 | −1,800 | $16.04 | $29K | 0 |
| 2023-06-02 | McArthur James G President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,800 | 354,504 | ||
| 2023-03-24 | Goyal Jaya EVP, Res. & Preclin. Dev. | Option exercise | +392 | $10.88 | $4K | 392 |
| 2023-03-24 | Goyal Jaya EVP, Res. & Preclin. Dev. | Sale | −392 | $20.00 | $8K | 0 |
| 2023-03-24 | Goyal Jaya EVP, Res. & Preclin. Dev. | Option exercise · Stock Option (Right to Buy) | −392 | 143,804 | ||
| 2023-03-01 | Mellion Michelle L SVP, Clinical Development | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2023-03-01 | Mellion Michelle L SVP, Clinical Development | Grant or award · Stock Option (Right to Buy) | +20,000 | 95,000 | ||
| 2023-03-01 | Goyal Jaya EVP, Res. & Preclin. Dev. | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 |
Page 8 of 11 · 211 trades